Amy Lin, Senior Vice President, Head of Global Portfolio Strategy
Amy Lin was named Senior Vice President, Head of Global Portfolio Strategy at Foundation Medicine in March 2020. Ms. Lin has an impressive track record of defining effective and thoughtful strategies and mobilizing large cross-functional teams to success. In her role, she oversees enterprise-wide functions across brand and portfolio marketing, corporate and product strategy, market insights and analytics, communications, and life cycle team management, in order to provide the maximum benefit to patients.
Current Open Roles on the Team:
| Sr Dir, Corporate Strategy & Corporate Development | Corporate Strategy | 101775 | Boston. Remote | Massachusetts | United States | Seaport Blvd., Boston, Massachusetts, United States. Remote, Massachusetts, United States | Global Portfolio Strategy | About the Job The Senior Director, Corporate Strategy & Corporate Development is responsible for setting the vision and leading a team that defines and shapes FMI’s corporate strategy and corporate development approach. This leadership-level rol... |
FBE is part of the larger Global Portfolio Strategy (GPS) Team, that works together and across the company to guide Foundation Medicine’s journey and develop the strategy that enables us to work toward our mission of transforming cancer care. The FBE teams play an important strategic role within GPS, aligning processes, insights, and training to ensure that the organization has the resources they need to successfully execute their roles.
Learn more about the FBE team here.
The Data and Insights Delivery team has a global scope focused on how our data – and the insights that we can generate from it – impacts the entire precision medicine ecosystem. At Foundation Medicine, one of our primary services is to provide the highest quality comprehensive genomic profiling to as many patients as possible every day. In DataID, we build upon the service in two distinct but related ways.
Learn more about the DataID team here.
Naima is currently the Director of Data Strategy Marketing and a part of the Data Insights and Delivery team within GPS. She is responsible for developing our commercialization strategy for our data products that are derived from the outputs of our diagnostic tests. Her role is global in nature, focused on two customer segments: Clinical and Biopharma.
Learn more about her role here.
Learn a bit more about us:
